Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024
Compare Balance Sheet Results of Shelter Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
11.56
3.18
8.38
263.52%
Share Warrants & Outstandings
Total Reserve
31.16
32.38
-1.22
-3.77%
Shareholder's Funds
42.72
35.56
7.16
20.13%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.93
0.49
0.44
89.80%
Secured Loans
0.00
0.49
-0.49
-100.00%
Unsecured Loans
0.93
0.00
0.93
0.00%
Deferred Tax Assets / Liabilities
-0.03
0.08
-0.11
-137.50%
Other Long Term Liabilities
0.05
0.00
0.05
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.95
0.57
0.38
66.67%
Current Liabilities
Trade Payables
1.25
1.82
-0.57
-31.32%
Other Current Liabilities
3.27
1.41
1.86
131.91%
Short Term Borrowings
0.11
3.72
-3.61
-97.04%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
4.63
6.95
-2.32
-33.38%
Total Liabilities
48.30
43.07
5.23
12.14%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
8.36
3.73
4.63
124.13%
Less: Accumulated Depreciation
2.39
1.24
1.15
92.74%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
5.96
2.49
3.47
139.36%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.68
0.00
0.68
0.00%
Long Term Loans & Advances
8.39
0.13
8.26
6,353.85%
Other Non Current Assets
0.00
0.05
-0.05
-100.00%
Total Non-Current Assets
15.03
2.67
12.36
462.92%
Current Assets Loans & Advances
Current Investments
0.00
2.35
-2.35
-100.00%
Inventories
12.90
1.88
11.02
586.17%
Sundry Debtors
9.47
4.15
5.32
128.19%
Cash and Bank
3.42
5.54
-2.12
-38.27%
Other Current Assets
1.77
0.86
0.91
105.81%
Short Term Loans and Advances
5.72
25.62
-19.90
-77.67%
Total Current Assets
33.28
40.40
-7.12
-17.62%
Net Current Assets (Including Current Investments)
28.65
33.46
-4.81
-14.38%
Total Current Assets Excluding Current Investments
33.28
38.05
-4.77
-12.54%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
48.30
43.07
5.23
12.14%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
1.04
4.21
-3.17
-75.30%
Book Value per share (adjusted)
36.14
111.88
-75.74
-67.70%
Annual - Borrowings
Borrowings 1.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 79.31% vs -67.42% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.05 Cr
in Mar 2025Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 5.96 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 66.48% vs 93.51% in Mar 2024
Annual - Investments
Investments 0.68 Cr
in Mar 2025Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 33.28 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.98% vs 58.76% in Mar 2024






